| Particulars |
|
|
|
| Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
132.30 |
| Sales(₹ Cr.) |
3,790.20 |
NP (₹ Cr.) |
907.82 |
| NP Var% |
10.00 |
Div% |
570.00 |
| CPS(₹) |
57.50 |
EPS (₹) |
53.60 |
| Traded Value(₹ Lakhs) |
104.55 |
52 Week High |
3,121.00 |
| 52 Week Low |
2,088.00 |
Price BSE |
2,787.00 |
| Price NSE |
2,784.00 |
Market Capital (₹ Cr.) |
47,217.70 |
| P/C Ratio |
48.50 |
P/E Ratio |
52.00 |
| Price Vs.BV |
21.07 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
924.42 |
| NP(₹ Cr.) |
253.33 |
NP Var % |
24.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
3,526.90 |
| OPM |
24.25 |
NP |
795.84 |
| NP Var% |
12.76 |
EPS |
62.48 |
| PE |
44.61 |
|
|